HORTEN, Norway — 21 February, 2024 — poLight ASA (OSE: PLT) today announced that PhenoSys, a leader in engineering and market innovative technology for animal behaviour research, offers a Mini2P turnkey solution that includes TLens® for optimal microscopic imaging. The PhenoSys system includes the miniature two-photon (Mini2P) microscope body for X-Y-Z plane scanning, fiber optics and cabling, two-photon laser, detection unit, flexible DAQ hardware and software, and full technical support. Mini2P is an open-source miniature two-photon microscope brain explorer developed by Kavli Institute for Systems Neuroscience at Norwegian University of Science and Technology. By recording live images of neural activity in naturally behaving animals, the Mini2P delivers critical insights into neurological illnesses such as Alzheimer’s and dementia.
“By offering the Mini2P innovative technology as a turnkey solution, we believe that hundreds of research labs around the world can implement a complete behavioural system within hours,” said Prof. York Winter, CEO of PhenoSys. “The low-power, fast, autofocus capabilities of the TLens® enables rapid shifts in focal plane scanning, enabling deeper, 3-D recordings of brain tissue. poLight’s tunable optics technology has been instrumental in the Mini2P solution and we look forward to future collaborations.”
“Following the Kavli Institute’s use of TLens® in their Mini2P innovation and subsequent Nobel Prize, we have seen strong interest from many research groups around the world who are interested in this unique device,” said Dr. Oyvind Isaksen, CEO of poLight ASA. “We are excited to see commercial players suppling the tools and resources to accelerate deployment of Mini2P systems. It is an honor to be a part of this ground-breaking technology, which is beginning to represent significant revenue for our company.”
To date, over the past one to two years, poLight has delivered TLenses to PhenoSys worth approximately NOK 1.500.000. A significant part of this relates to the announcement released 25 September 2023.